Skip to main content

Published locations for First drug for lung cancer with KRAS mutation gains FDA approval

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First drug for lung cancer with KRAS mutation gains FDA approval

User login

  • Reset your password
  • /content/first-drug-lung-cancer-kras-mutation-gains-fda-approval
  • /oncologypractice/article/240821/lung-cancer/first-drug-lung-cancer-kras-mutation-gains-fda-approval
  • /fedprac/avaho/article/240821/lung-cancer/first-drug-lung-cancer-kras-mutation-gains-fda-approval
  • /jcomjournal/article/240821/lung-cancer/first-drug-lung-cancer-kras-mutation-gains-fda-approval
  • /hematology-oncology/article/240821/lung-cancer/first-drug-lung-cancer-kras-mutation-gains-fda
  • /chestphysician/article/240821/lung-cancer/first-drug-lung-cancer-kras-mutation-gains-fda-approval